Reduced Vitamin K Status as a Potentially Modifiable Prognostic Risk Factor in COVID-19 (Dofferhoff AS et al.) Posted June 15, 2020 by Cloud 9
High dephospho-uncarboxylated matrix Gla protein concentrations, a plasma biomarker of vitamin K, in relation to frailty: the Longitudinal Aging Study Amsterdam (Machado‑Fragua MD et al.) Posted June 15, 2020 by Cloud 9
Vitamin K2 Alleviates Insulin Resistance in Skeletal Muscle by Improving Mitochondrial Function via SIRT1 Signaling (Su X et al.) Posted June 15, 2020 by Cloud 9
Early vascular ageing in chronic kidney disease: impact of inflammation, vitamin K, senescence and genomic damage (Dai L et al.) Posted June 15, 2020 by Cloud 9
Locking and loading the bullet against micro-calcification (Florea A et al.) Posted June 15, 2020 by Cloud 9
Vitamin K-Dependent Matrix Gla Protein as Multifaceted Protector of Vascular and Tissue Integrity (Wei FF et al.) Posted October 17, 2019 by Cloud 9
Central Hemodynamics in Relation to Circulating Desphospho-Uncarboxylated Matrix Gla Protein: A Population Study (Wei FF et al.) Posted October 17, 2019 by Cloud 9
Vitamin K1 Supplementation Did Not Alter Inflammatory Markers and Clinical Status in Patients with Rheumatoid Arthritis (Shishavan NG et al.) Posted October 17, 2019 by Cloud 9
Circulating phylloquinone, inactive Matrix Gla protein and coronary heart disease risk: A two-sample Mendelian Randomization study (Zwakenberg SR et al.) Posted October 17, 2019 by Cloud 9
Supplementary nutrients for prevention of vascular calcification in patients with chronic kidney disease (Lee SM and An WS) Posted October 17, 2019 by Cloud 9